OTCMKTS:SNYNF Sanofi (SNYNF) Stock Price, News & Analysis $77.98 -2.37 (-2.95%) As of 02:22 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsNews and TrendsSEC Filings About Sanofi Stock (OTCMKTS:SNYNF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sanofi alerts:Sign Up Key Stats Today's Range$77.49▼$79.8250-Day Range$79.96▼$93.4552-Week Range$77.49▼$106.34Volume4,468 shsAverage Volume28,006 shsMarket CapitalizationN/AP/E Ratio25.28Dividend Yield3.59%Price TargetN/AConsensus RatingN/A Company Overview Sanofi is a France-based global biopharmaceutical company that researches, develops, manufactures and markets medicines and vaccines. Its portfolio focuses on immunology, rare diseases, vaccines, specialty care and established prescription medicines, serving patients and healthcare providers in markets around the world. The company’s products include Dupixent for several inflammatory conditions, Beyfortus for the prevention of respiratory syncytial virus disease in infants, and vaccines for influenza, meningococcal disease, polio and other conditions. Sanofi also offers treatments across areas such as diabetes, cardiovascular disease, oncology and rare diseases. Sanofi traces its roots to French pharmaceutical businesses established during the 20th century and became Sanofi-Aventis following the 2004 acquisition of Aventis. The company adopted the Sanofi name in 2011. Its global operations span research, manufacturing and commercial activities across North America, Europe, Asia and other international markets. Sanofi is led by Chief Executive Officer Paul Hudson.AI Generated. May Contain Errors. Read More Receive SNYNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SNYNF Stock News HeadlinesDeutsche Bank Sticks to Its Buy Rating for Sanofi (SNYNF)September 15, 2026 | theglobeandmail.comRBC Capital Initiates a Hold Rating on Sanofi (SNYNF)September 9, 2026 | theglobeandmail.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 2 at 1:00 AM | Porter & Company (Ad)Sanofi (SNYNF) Gets a Hold from UBSAugust 20, 2026 | theglobeandmail.comAnalysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF), Ligand Pharma (LGND) and Exelixis (EXEL)August 12, 2026 | theglobeandmail.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Qiagen (QGEN) and Sanofi (OtherSNYNF)August 8, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Align Tech (ALGN)July 26, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Ocular Therapeutix (OCUL)June 24, 2026 | theglobeandmail.comSee More Headlines SNYNF Stock Analysis - Frequently Asked Questions How have SNYNF shares performed this year? Sanofi's stock was trading at $97.2950 at the start of the year. Since then, SNYNF stock has decreased by 19.9% and is now trading at $77.9760. How do I buy shares of Sanofi? Shares of SNYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/02/2026Next Earnings (Estimated)10/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:SNYNF CIK1121404 Webwww.sanofi.com Phone(315) 377-4000FaxN/AEmployees91,600Year Founded2004Profitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio25.28 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:SNYNF) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altuche...Paradigm Press | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredMajor Buy Alert Issued for October 31stKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNYNF Stock Alerts